ArticleCureus2026
Multisystem Complications in Spinal Muscular Atrophy Type III: Chronic Respiratory Failure and Intractable Epilepsy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinal muscular atrophy (SMA) is a rare neuromuscular disorder characterized by progressive motor weakness with multisystem involvement. Type III SMA, also known as Kugelberg-Welander disease, typically presents in childhood and allows survival into adolescence and adulthood, during which cumulative complications may emerge. We report the case of a 19-year-old female patient with genetically confirmed SMA type III (zero copies of SMN1, two copies of SMN2) whose disease course was complicated by chronic respiratory failure with hypercapnia requiring non-invasive ventilation and intractable generalized epilepsy. She was born prematurely at seven and a half months via emergent cesarean section for placenta previa and maternal hemorrhage, requiring a one-month neonatal intensive care unit stay with supplemental oxygen. SMA was diagnosed at 28 months of age following early motor weakness. Over childhood, she developed choking with thin liquids, weak cough during viral illnesses, and recurrent respiratory infections, with progression to restrictive lung disease and impaired airway clearance. At age 11, she developed head-drop seizures and was diagnosed with intractable generalized idiopathic epilepsy. Orthopedic complications included neuromuscular scoliosis requiring spinal fusion. This case underscores how SMA type III evolves into a multisystem disorder with cumulative respiratory, neurologic, and orthopedic morbidity, highlighting the need for vigilant longitudinal surveillance, proactive respiratory support, individualized seizure management, and coordinated interdisciplinary care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.